EMG
ALXN

ETF Managers Group’s Alexion Pharmaceuticals ALXN Stock Holding History

ETF Managers Group’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-2,048
Closed -$377K – 739
2021
Q2 		$377K Sell
2,048
-389
-16% -$66.8K 0.01% 569
2021
Q1 		$374K Sell
2,437
-660
-21% -$102K 0.01% 559
2020
Q4 		$484K Sell
3,097
-197
-6% -$25.3K 0.01% 360
2020
Q3 		$370K Buy
+3,294
New +$355K 0.01% 378
2019
Q3 		– Sell
-3,204
Closed -$404K – 590
2019
Q2 		$404K Sell
3,204
-10,448
-77% -$1.35M 0.01% 263
2019
Q1 		$1.84M Sell
13,652
-3,917
-22% -$487K 0.09% 110
2018
Q4 		$1.71M Sell
17,569
-2,485
-12% -$294K 0.08% 136
2018
Q3 		$2.79M Buy
+20,054
New +$2.52M 0.11% 102
2016
Q1 		$22K Buy
+181
New +$26.6K 0.02% 449

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $13.1B AUM 28.37% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $434M AUM 44.19% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $1.1B AUM 26.6% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.96B AUM 48.96% 1-Year Est. Return

ETF Managers Group's ALXN Position: Q3 2021 in Review

ETF Managers Group sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 2,048 shares — an estimated $377K sold.

ETF Managers Group first reported a position in ALXN in Q1 2016 and held it in 9 quarters. The position peaked at $2.79M in Q3 2018. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

  • ETF Managers Group reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • ETF Managers Group sold 2,048 Alexion Pharmaceuticals shares in Q3 2021, an estimated $377K.
  • ETF Managers Group first reported a position in Alexion Pharmaceuticals in Q1 2016 and held it in 9 quarters.
  • ETF Managers Group's Alexion Pharmaceuticals position peaked at $2.79M in Q3 2018.
  • 7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on ETF Managers Group's 13F filing for Q3 2021, filed 15 Nov 2021.